RadioEmbolization for the ADvancement of Y90 Glass Microspheres Registry (READ90Y)
Sponsor: Biocompatibles UK Ltd
Terminated
due to Sponsor's ongoing and upcoming projects and overall research priorities
Other terminated trials from Biocompatibles UK Ltd
- Hepatocellular Carcinoma · Phase PHASE3 · May 2017
- Colorectal Cancer · Phase PHASE2 · May 2015
- Unresectable Metastatic Colo-rectal Cancer · Phase PHASE1/PHASE2 · Mar 2011
More terminations from Biocompatibles UK Ltd
Listed as NCT03516695, this observational or N/A phase trial focuses on Liver Cancer and remains terminated or withdrawn. Sponsored by Biocompatibles UK Ltd, it has been updated 6 times since 2018, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
May 2021 — Jul 2024 [monthly]
Terminated
-
Jan 2021 — May 2021 [monthly]
Terminated
-
Apr 2019 — Jan 2021 [monthly]
Terminated
Status: Recruiting → Terminated
▶ Show 1 earlier version
-
Jun 2018 — Apr 2019 [monthly]
Recruiting
First recorded
Feb 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Biocompatibles UK Ltd
- Boston Scientific Corporation
For direct contact, visit the study record on ClinicalTrials.gov .